177 related articles for article (PubMed ID: 10541418)
1. Comparative clinical effectiveness of long-term controller therapy for asthma.
Kelly HW
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):269-70. PubMed ID: 10541418
[No Abstract] [Full Text] [Related]
2. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
Holt S; Masoli M; Beasley R
J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
[No Abstract] [Full Text] [Related]
3. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
5. Adrenal suppression with inhaled corticosteroids.
Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
[No Abstract] [Full Text] [Related]
6. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
Kamada AK; Szefler SJ; Martin RJ; Boushey HA; Chinchilli VM; Drazen JM; Fish JE; Israel E; Lazarus SC; Lemanske RF
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1739-48. PubMed ID: 8665030
[No Abstract] [Full Text] [Related]
7. Flunisolide for the treatment of asthma.
Melani AS
Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
[TBL] [Abstract][Full Text] [Related]
8. Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship.
Lipworth BJ
Pulm Pharmacol; 1996 Feb; 9(1):19-27. PubMed ID: 8843506
[No Abstract] [Full Text] [Related]
9. [Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma].
Bergmann KC
Pneumologie; 1997 Jan; 51(1):27-32. PubMed ID: 9132744
[TBL] [Abstract][Full Text] [Related]
10. Treatment with inhaled flunisolide.
Edmonds ML; Rowe BH
Chest; 2004 May; 125(5):1961-2; author reply 1962-3. PubMed ID: 15136418
[No Abstract] [Full Text] [Related]
11. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.
Kantar A; Mroueh S; Fiocchi A
Allergy Asthma Proc; 2007; 28(6):671-87. PubMed ID: 17883883
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
13. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[TBL] [Abstract][Full Text] [Related]
14. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2015; 9(2):144-50. PubMed ID: 26581314
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Azmacort MDI and Flovent Diskhaler.
Deslandes B; Lim J; Staudinger H
J Allergy Clin Immunol; 1998 Jul; 102(1):154-5. PubMed ID: 9679864
[No Abstract] [Full Text] [Related]
17. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
Tarsin WY; Pearson SB; Assi KH; Chrystyn H
Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
[TBL] [Abstract][Full Text] [Related]
18. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
20. Nebulized corticosteroids in asthma and COPD. An Italian appraisal.
Melani AS
Respir Care; 2012 Jul; 57(7):1161-74. PubMed ID: 22272733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
